| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 10,673 | 9,190 | 5,639 | 5,635 | | Cost of Revenue | 7,937 | 6,655 | 3,951 | 3,896 | | | Gross Profit | 2,736 | 2,535 | 1,688 | 1,739 | | | Operating Expenses | | Research Development | 1,880 | 1,127 | 777 | 872 | | Selling General and Administrative | 3,502 | 3,048 | 2,742 | 2,639 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,646) | (1,640) | (1,831) | (1,772) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (18) | 34 | 12 | 92 | | Earnings Before Interest And Taxes | (2,658) | (1,606) | (1,819) | (1,681) | | Interest Expense |
-
|
-
| 6 |
-
| | Income Before Tax | (2,658) | (1,606) | (1,825) | (1,681) | | Income Tax Expense | (1,042) | (628) | (712) | (657) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,616) | (978) | (1,113) | (1,024) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,616) | (978) | (1,113) | (1,024) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,616) | ($978) | ($1,113) | ($1,024) |
|
0.31% Nasdaq 0.00%
Income Statement
